296 results on '"Hautmann, Matthias"'
Search Results
2. Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma – knowledge obtained from the CheckRad-CD8 trial
3. ArthroRad trial: multicentric prospective and randomized single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis depending on the dose—results after 3 months’ follow-up
4. De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status--results of a prospective multicenter phase II trial (DIREKHT Trial).
5. Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines
6. RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
7. Infiltrating immune cells are associated with radiosensitivity and favorable survival in head and neck cancer treated with definitive radiotherapy
8. Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial
9. Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma—a review
10. Implant survival or implant success? Evaluation of implant-based prosthetic rehabilitation in head and neck cancer patients—a prospective observational study
11. Radiotherapy for osteoarthritis—an analysis of 295 joints treated with a linear accelerator
12. Radiotherapy for osteoarthritis of the ankle and tarsal joints—analysis of 66 joints
13. Re-irradiation for humeral epicondylitis: Retrospective analysis of 99 elbows
14. Reactivity of [{(N3N)W[tbnd]P] towards Gold(I) salts – Synthesis of [{(N3N)W[tbnd]P[sbnd]AuCl] and [{(N3N)W[tbnd]P}2Au][pftb] (pftb = Al(OC(CF3)3)4)
15. Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer—a meta-analysis
16. Re-irradiation for osteoarthritis—retrospective analysis of 217 joints
17. Radiotherapy of patients with cardiac implantable electronic devices according to the DEGRO/DGK guideline—is the risk of relevant errors overestimated?
18. Radiotherapy of epicondylitis humeri: Analysis of 138 elbows treated with a linear accelerator
19. Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma
20. ArthroRad trial: randomized multicenter single-blinded trial on the effect of low-dose radiotherapy for painful osteoarthritis—final results after 12-month follow-up
21. Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
22. Is low dose radiotherapy an effective treatment for Baker’s cyst?
23. Impact of radiotherapy on implant-based prosthetic rehabilitation in patients with head and neck cancer: A prospective observational study on implant survival and quality of life—Preliminary results
24. Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients
25. Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck
26. Supplementary Data from Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
27. Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
28. Total nodal irradiation in patients with severe treatment-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation: Response rates and immunomodulatory effects
29. AKT and MET signalling mediates antiapoptotic radioresistance in head neck cancer cell lines
30. Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck: Final 5‑year results of a phase II study
31. Radiotherapy of painful heel spur with two fractionation regimens: Results of a randomized multicenter trial after 48 weeks’ follow-up
32. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma
33. Die Rolle der Beckenbestrahlung beim nodal-negativen Adenokarzinom der Prostata bleibt unklar: Langzeitergebnisse der GETUG-01-Studie
34. Cycling CD34 expression in subpopulations of head and neck squamous cell carcinoma cell lines is involved in radioresistance and change in cytokeratin expression profile
35. Tumor-Induced Osteomalacia: an Up-to-Date Review
36. Therapy of advanced head and neck cancer with double checkpoint blockade followed by radioimmunotherapy – results of the CheckRad-CD8 study.
37. Hodgkin-Lymphom in Kindheit oder Jugend: Keine niedrigere Mutterschaftsrate nach Bestrahlungen außerhalb des Beckens
38. Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer
39. Radiation Therapy of Lymphatic Fistulae After Vascular Surgery in the Groin
40. Workload and Quality of Life of Medical Doctors in the Field of Oncology in Germany - a Survey of the Working Group Quality of Life of the AIO for the Study Group of Internal Oncology
41. Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer—Comparison of a Prospective Trial with a Revised Simulated Contouring Approach
42. Vergleich der Rezidivmuster beim Ösophaguskarzinom nach alleiniger Operation und Operation nach neoadjuvanter Radiochemotherapie: Eine Sekundärauswertung der CROSS-Studien
43. Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial
44. A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer
45. Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T-cell infiltration.
46. Significance of site‐specific radiation dose and technique for success of implant‐based prosthetic rehabilitation in irradiated head and neck cancer patients—A cohort study
47. A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer
48. Implementation of double immune checkpoint blockade increases response rate to induction chemotherapy in head and neck cancer
49. Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer
50. Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma—a review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.